Ann: Bodyguard Results, page-100

First 100 Last

Share
Profile

Follow
LeeKing

5,891 Posts.

226

23/02/16

13:52

Post #: 17093085
Share
Originally posted by Charles89 ↑

Just going through the numbers provided about the participants:

Best product ever tried - 3 in 10 - 30%

Would definitely buy - 1 in 4 - 25%

4/5 star user experience - 51 in 100 - 51%

3 star user experience - 1 in 3 - 33.33%

I think from the numbers above, we can confirm that:

BG can definitely capture a minimum of 25% market share

84.33% of participants rates the user experience 50% or higher

15.67% rated the user experience 1-2 stars

While here are other things to consider (not facts but just educated guess):

49% of people may have rated 1-3 starts because of skin irritations

Due to "higher skin irritation levels", it may be the reasons why some of the 70% people may not definitely buy BG (100%-30% - best product ever tried), but since that problem is now eliminated "with the adoption of a new Hydrogen gel technology", we may be able to capture more participant to buy BG

If before the skin irritation issue was fixed, BG can capture 25% people, then if we get rid of the skin irritations, BG may be able to capture a further 25% of the 75% that won't definitely not buy BG. So together with the original 25% and 25% of 75%, equals 42.5% that could definitely buy BG.

And if skin irritation is another factor that caused a bad user experience, we may be able to convert roughly half of them them to a 4-5 star after it's fixed, which will roughly give a 75% to a 4/5 stars user experience. OR maybe roughly 90% to a 3+ stars experience.

I think the stats would look much more appealing once BG fixes the skin irritation side of things, while "further enhance efficacy of Kneeguard."

Expand

The data is wildly incomplete, and the whole trial quite unreliable, IMO.

Presented info could be all cherry picking.

You're putting positive spin. Just as easy to put negative spin. For example: Skin irritation might have caused people to reduce effort, leading to better internal knee pain results.
OBJ Price at posting: 6.9¢ Sentiment: None Disclosure: Not Held
4 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

What each US election outcome would mean for Australian companies & investors

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Making money: How many microcaps should be in an investor's portfolio?

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too